0001610717-24-000182.txt : 20240322
0001610717-24-000182.hdr.sgml : 20240322
20240322164213
ACCESSION NUMBER: 0001610717-24-000182
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240320
FILED AS OF DATE: 20240322
DATE AS OF CHANGE: 20240322
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GRAMMER ELIZABETH A
CENTRAL INDEX KEY: 0001213041
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36485
FILM NUMBER: 24775864
MAIL ADDRESS:
STREET 1: 78TH FOURTH AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARDELYX, INC.
CENTRAL INDEX KEY: 0001437402
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 34175 ARDENWOOD BLVD.
CITY: FREMONT
STATE: CA
ZIP: 94555
BUSINESS PHONE: 510-745-7047
MAIL ADDRESS:
STREET 1: 34175 ARDENWOOD BLVD.
CITY: FREMONT
STATE: CA
ZIP: 94555
FORMER COMPANY:
FORMER CONFORMED NAME: NTERYX INC
DATE OF NAME CHANGE: 20080611
4
1
form4.xml
X0508
4
2024-03-20
0001437402
ARDELYX, INC.
ARDX
0001213041
GRAMMER ELIZABETH A
78TH FOURTH AVENUE
WALTHAM
MA
02451
true
See Remarks
true
Common Stock
2024-03-20
4
S
0
86000
7.7323
D
312993
D
Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 20, 2023.
This transaction was executed in multiple trades in prices ranging from $7.65 to $7.92, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Chief Legal and Administrative Officer
/s/ Elizabeth Grammer
2024-03-22